Sell the company and be done with it?, page-9

Hmmm buying Yeah that is really averaging down . Outright buy at bottom ( wherever that is) will be a legend once in a lifetime opportunity ( just don't get many opportunity with such innovative technology) as I don't see these guys going broke but I do see them starved of cash and more and more the slave to vested interests with visibility of board meetings. My problem is that ERB has been there a while and we are not sure internally just how much progress has been made to date on new strategy. Slowness of this change and lack of urgency keeps me from investing more. I want to see some results of turnaround and also understand costs of closing down trials? Still have to support existing patients?
I have to see new protocol and what is required
Semi you must have bottomless pockets!!! ha ha